Novel hepcidin antagonist

Neurotoxin, acting via vanilloid receptors of sensory nerves

Novel pan-histone-deacetylase inhibitor with alkylating activity

Antiviral, antineoplastic, and anti-inflammatory agent; Orally active interferon inducer, inhibiting Ebola virus (EBOV)

Macrolide antibiotic for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica

Widely used oxidation-reduction indicator

Natural anticancer agent fortreatment of mast cell tumor (MCT)

Muscarinic receptor antagonist, anticholinergic,and parasympatholytic

Anthraquinone-fused enediyne antitumor agent for development of antibody-drug conjugates (ADCs)

Anti-epileptic and anticonvulsant agent, acting as a selective GABA reuptake inhibitor

Novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor

Novel selective thrombin inhibitor, inducing conformational allostery

Novel dose-dependent inhibitor of HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9; NOX Inhibitor

Phosphodiesterase 10A (PDE10A) inhibitor

Novel phosphodiesterase 10A (PDE10A) inhibitor for treatment of schizophrenia

Novel potent, highly selective and orally available PI3Kδ inhibitor

Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent

Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent

Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent

Selective Tau ligand, selectively binding to neurofibrillary tangles and neuropils in people with Alzheimer's disease

Steroidomimetic and Chimeric Microtubule Disruptor

Novel inducer of apoptotic cell death in platinum-resistant A2780cis human ovarian cancer cells, exhibitong a strong inhibitory effect in ovarian CSC-LCs in combination with cisplatin

Novel Potent Inhibitor of the Opioid Receptors and the Ion Channels

GABAA receptor agonist

Firefly luciferin analog as a key element of bioluminescent reporters for oxidation state and thiol/disulfide equilibria

Novel potent DENV2-NS2B/NS3pro inhibitor

First-in-class potent, selective, reversible, and tight binding inhibitor of human monoamine oxidase B (hMAO-B) (hMAO-B IC 50 = 1.52 ± 0.15 nM)

Novel selective anticancer agent, selectively inducing cancer cell death in a caspase independent pathway

Novel protein-protein interaction inhibitor of PAC3 homodimer

Highly efficient bioregulator of plant morphogenesis in the tissue culture technique, inducing diverse responses ranging from induction of callus to embryogenesis or organogenesis, acting through modulation of the endogenous plant growth regulators, modif